Discordance Between Phenotypic and WGS-Based Drug Susceptibility Testing Results for Some Anti-Tuberculosis Drugs: A Snapshot Study of Paired

drug resistance phenotypic drug susceptibility testing tuberculosis whole-genome sequencing

Journal

Infection and drug resistance
ISSN: 1178-6973
Titre abrégé: Infect Drug Resist
Pays: New Zealand
ID NLM: 101550216

Informations de publication

Date de publication:
2024
Historique:
received: 15 03 2024
accepted: 11 07 2024
medline: 7 8 2024
pubmed: 7 8 2024
entrez: 7 8 2024
Statut: epublish

Résumé

Current tuberculosis treatment regimens primarily rely on phenotypic drug susceptibility testing and rapid molecular assays. Although whole-genome sequencing (WGS) offers a promising alternative, disagreements between phenotypic and molecular testing methods remain. In this retrospective study, we compared the phenotypic and WGS-predicted drug resistance profiles of paired Paired Among the 46 isolate pairs, 25 (54.3%) harbored drug-resistance-associated variants, with 20 demonstrating identical WGS-predicted drug resistance profiles. Drug-resistant isolate pairs belonged to Lineages 2 and 4, with the most common sub-lineages being 2.2.1 (SIT1 and SIT190 spoligotypes), and 4.3.3 (SIT42). Agreement between phenotypic and WGS-based drug susceptibility testing was highest (>90%) for rifampicin, isoniazid, ethambutol, fluoroquinolones, streptomycin, and amikacin when calculated for The simultaneous performance of phenotypic and WGS-based drug susceptibility testing creates the most accurate drug resistance profile for

Sections du résumé

Background UNASSIGNED
Current tuberculosis treatment regimens primarily rely on phenotypic drug susceptibility testing and rapid molecular assays. Although whole-genome sequencing (WGS) offers a promising alternative, disagreements between phenotypic and molecular testing methods remain. In this retrospective study, we compared the phenotypic and WGS-predicted drug resistance profiles of paired
Methods UNASSIGNED
Paired
Results UNASSIGNED
Among the 46 isolate pairs, 25 (54.3%) harbored drug-resistance-associated variants, with 20 demonstrating identical WGS-predicted drug resistance profiles. Drug-resistant isolate pairs belonged to Lineages 2 and 4, with the most common sub-lineages being 2.2.1 (SIT1 and SIT190 spoligotypes), and 4.3.3 (SIT42). Agreement between phenotypic and WGS-based drug susceptibility testing was highest (>90%) for rifampicin, isoniazid, ethambutol, fluoroquinolones, streptomycin, and amikacin when calculated for
Conclusion UNASSIGNED
The simultaneous performance of phenotypic and WGS-based drug susceptibility testing creates the most accurate drug resistance profile for

Identifiants

pubmed: 39108991
doi: 10.2147/IDR.S468997
pii: 468997
pmc: PMC11300831
doi:

Types de publication

Journal Article

Langues

eng

Pagination

3289-3307

Informations de copyright

© 2024 Sadovska et al.

Déclaration de conflit d'intérêts

The authors declare that they have no competing interests in this work.

Auteurs

Darja Sadovska (D)

Latvian Biomedical Research and Study Centre, Riga, Latvia.

Anda Nodieva (A)

Riga East University Hospital, Centre of Tuberculosis and Lung Diseases, Stopiņi region, Upeslejas, Latvia.

Ilva Pole (I)

Latvian Biomedical Research and Study Centre, Riga, Latvia.
Riga East University Hospital, Centre of Tuberculosis and Lung Diseases, Stopiņi region, Upeslejas, Latvia.

Anda Vīksna (A)

Riga East University Hospital, Centre of Tuberculosis and Lung Diseases, Stopiņi region, Upeslejas, Latvia.
Department of Infectology, Riga Stradiņš University, Riga, Latvia.

Jānis Ķimsis (J)

Latvian Biomedical Research and Study Centre, Riga, Latvia.

Iveta Ozere (I)

Riga East University Hospital, Centre of Tuberculosis and Lung Diseases, Stopiņi region, Upeslejas, Latvia.
Department of Infectology, Riga Stradiņš University, Riga, Latvia.

Inga Norvaiša (I)

Riga East University Hospital, Centre of Tuberculosis and Lung Diseases, Stopiņi region, Upeslejas, Latvia.

Ineta Bogdanova (I)

Riga East University Hospital, Centre of Tuberculosis and Lung Diseases, Stopiņi region, Upeslejas, Latvia.

Dace Bandere (D)

Department of Pharmaceutical Chemistry, Riga Stradiņš University, Riga, Latvia.

Renāte Ranka (R)

Latvian Biomedical Research and Study Centre, Riga, Latvia.

Classifications MeSH